Current Frontline Treatment of Multiple Myeloma.
Treatment paradigms for management of newly diagnosed (ND) multiple myeloma have been evolving over the past 20 years as a consequence of the development of immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies. While recent studies have continued to confirm the progression-free s...
| Publicado en: | Oncology (08909091) Vol. 36; no. 7; pp. 430 - 442 |
|---|---|
| Autor principal: | |
| Formato: | review tables/charts Journal Article |
| Publicado: |
MJH Life Sciences
Jul2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |